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Short and long dolichols and polyprenols in free form or esterified with fatty acids were incorporated into liposomes 
and administered to rats through agastric tube. The free alcohols were taken up by the liver to different extents. While 
uptake in other organs was less, it also involved the fatty acid esters. The use of systems other than liposomes did not 
increase the efficiency of uptake. Most of the administered lipids were recovered in the lysosomes. Exogenous dolichols 
and potyprenols were both partly esterified inthe liver and, to some xtent, also phosphorylated; a portion of the poly- 
prenols was also ~t-saturated. These results indicate that various polyisoprenes are taken up, to a small extent, from the 
diet by tissues under normal conditions and in liver these dietary lipids undergo terminal modifications. 
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1. INTRODUCTION 
The main products of the mevalonate pathway, 
i.e., cholesterol, ubiquinone and dolichol, are syn- 
thesized in most tissues so far investigated and 
these lipids are regarded as playing obligatory roles 
in basic cellular functions [1]. On the other hand, 
it is well established that a considerable portion of 
the cholesterol utilized in metabolic processes i not 
synthesized e novo in the cell, but is supplied in 
the diet. Concerning ubiquinone it was proposed 
that a few percent of this lipid in the tissues 
originates from the diet [2]. Uptake of poly- 
isoprenoid lipids from the diet has been studied 
much less than the uptake of cholesterol or ubi- 
quinone. Concerning a-saturated and a- 
unsaturated polyisoprenoids, it was found in 
previous experiments that undecaprenol (poly- 
prenol-11) supplied orally is taken up through the 
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gastrointestinal system to a small extent [3], while 
dolichol-19 administered orally to the rat did not 
appear in any appreciable amount in the liver [4]. 
Possibilities arise that the nature of the 
polyisoprenoid and the route of its administration 
may be critical to the uptake process and that these 
lipids are selectively utilized. 
The normal diet contains a rich supply of both a- 
unsaturated and a-saturated polyprenols from 
both plant and animal sources. A small dietary up- 
take may not necessarily be unimportant, since the 
liver and other organs are capable of modifying 
these lipids to metabolically more active species. 
Such modification may involve a-saturation, 
phosphorylation by a specific kinase, dephos- 
phorylation by a phosphatase, sterification with a 
fatty acid and/or elongation [5]. 
In the present study different polyprenols were 
administered to rats in different mixtures to deter- 
mine whether the rates of uptake were different. It 
appears that the conditions used affect he entrance 
of these lipids into the body, but that the net up- 
take is in all cases quite limited. 
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2. MATERIALS AND METHODS 
Male Spraque-Dawley rats weighing 180 g were used in these 
experiments. The animals were fasted for 20 h before ad- 
ministering the lipid emulsion (1.5 ml) into the stomach through 
a gastric tube attached to a syringe. 
The lipid emulsion was prepared by dissolving 30 mg egg 
lecithin (Lipid Products, South Nutfield, England) in 
chloroform/methanol, 2:1 and subsequently mixing with 1-2 
mg labeled polyisoprenoids (14 x 106 dpm). After evaporation 
of the solvent, 3 ml of 0.9070 NaCl was added and the tube 
vortexed for 3 min. This mixture was maintained in an ice-cold 
water bath and under a nitrogen atmosphere and sonicated inin- 
tervals for 6 min. The final mixture had a clear appearance. 
Homogenization f the various organs in 0.25 M sucrose was 
performed with an Ultra-Turrax homogenizer. The mito- 
chondrial-lysosomal, microsomal and supernatant fractions 
were prepared as described earlier [6]. The mitochondrial frac- 
tion isolated by differential centrifugation contains the majority 
of the lysosomes. Since upon gradient fractionation only a part 
of these lysosomes can be isolated and since polyisoprenols are 
present only in very low concentrations in mitochondria, the 
combined mitochondrial-lysosomal fraction is considered tobe 
the most appropriate fraction to use for assaying lysosomal 
polyprenol content. 
A mixture containing 12.5 ml methanol, 6.25 ml chloroform 
and 5 ml homogenate or particle suspension was incubated at 
40°C for 1 h for lipid extraction. The protein precipitate was 
reextracted with 6.25 ml chloroform at 40°C for 30 min. The 
combined extracts were seperated into two phases by the addi- 
tion of 6.5 ml water and the chloroform phase was washed twice 
wi*.h theoretical upper phase [7]. After evaporation of the sol- 
vent, radioactivity was determined by scintillation counting. 
When dolichol, polyprenol and their esterified erivatives 
were to be separated, these lipids dissolved in methanol were 
purified on a C-18 cartridge (Supelco) and the free alcohols and 
esterified erivatives were isolated by high-performance liquid 
chromatography (HPLC) on a C-18 column [8]. For separation 
of the c~-unsaturated and c~-saturated forms, HPLC on a silica 
column was employed [9]. When polyprenyl-P or dolichyl-P 
were to be isolated, the tissue suspensions were first subjected to 
alkaline hydrolysis and then the lipid extracts were purified by 
DEAE-Sephadex chromatorgraphy. 
Dolichyl-P and polyprenyl-P were isolated by HPLC using a 
C-18 column in the presence of 20 mM phosphoric acid [8]. 
Polyprenol-7 was isolated from Betula verrucosa, poly- 
prenol-12 from Pinus silvestris and polyprenol-19 from Gingko 
biloba [10l. a-saturation was performed by the method of 
Mankowski et al. [10]. The labeling of polyisoprenols with 
tritium was performed using NaB3I-h (Amersham, England; 
spec. act. 16.5 Ci/mmol) according to Keenan and Kruczek [11]. 
Esterification ofvarious polyprenols and dolichols was achieved 
with palmitoyl chloride [12]. 
3. RESULTS 
Various types of labeled polyisoprenols incor- 
porated into liposomes were introduced into the 
stomach through agastric tube and the appearance 
of the lipids in tissues 20 h later was analyzed (table 
1). The amount of radioactive lipid recovered inthe 
liver homogenate was clearly dependent on the 
nature of the compound administered. Relatively 
high uptake was obtained with polyprenol-12, ex- 
ceeding to some extent the uptake of 
polyprenol-19. Uptake of dolichol was less effi- 
cient than that of its c~-unsaturated counterpart. 
The use of esterified derivatives of both a- 
unsaturated and c~-saturated polyisoprenes 
eliminated completely their appearance in liver. 
In stomach and intestine, uptake of both short 
and long polyprenols occurred and no major dif- 
Table 1 
Uptake of various dietary polyprenols into organs of the rat 
Uptake (dpm per g wet weight) 
Organ Pol-19 Pol-19- Dol-19 Dol-19- Pol-12 Pol-12- Dol-12 Dol-7 
-FA -FA -FA 
Liver 52 212 543 21 382 397 93 642 2303 69 368 8719 
Kidney 5260 5731 2154 1017 4036 4274 
Thyroid 2070 4341 781 509 1219 3026 
Fat 736 1505 1010 1159 1024 1469 
Lung 6719 19 490 5099 2697 8911 7305 
Brain 707 2981 322 719 1724 3115 
Spleen 1007 1962 808 786 2188 3291 
Testis 820 2332 1127 517 1815 3740 
Stomach 23 875 49 724 39 118 40 188 30 870 31 416 
Intestine 8700 26 173 10 303 4002 4805 5240 
Muscle 1425 7031 661 1281 7067 2671 
The values represent the means of 5-7 experiments. For the sake of clarity, no SE are presented 
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Table 2 
Influence of the form of administration on 
[3H]polyisoprenol-12 uptake in liver 
Form administered Uptake 
(dpm/g wet weight) 
Lipsomes 93 642 _+ 7679 
In ethanol 74 281 + 7502 
In bile 33 459 _ 3680 
In corn oil 20 346 _+ 1506 
The PreParation of lipsomes is described in section 2. The la- 
beled polyprenol was suspended in 95% ethanol, rat bile or corn 
oil. The suspension with rat bile was sonicated for 3 min. The 
values are the means _+ SE of 6 experiments 
ferences were observed when c~-saturated or a- 
unsaturated lipids were administered. In contrast 
to the findings with liver, equal amounts of the 
esterified forms were also recovered in the 
homogenates from stomach and intestine. In the 
other organs examined the amount of radioactive 
lipid varied, being relatively high in kidney and 
lung and lower in other tissues. In all of these 
organs no selection was apparent when the uptake 
of different alcohols and their esterified erivatives 
was compared. 
The uptake of lipids from the intestine is 
regulated by a number of physical parameters and 
the possibility arose that the lipid mixture as sup- 
plied was in a form which was taken up inefficient- 
ly. When dolichol was sonicated in an anqueous 
medium together with egg lecithin, electron 
microscopy demonstrated the formation of single 
unilamellar vesicles. This mixture was suitable for 
studying the uptake of polyprenol-12 into the liver 
(table 2). Using an ethanol solution as carrier in- 
stead of lipsomes, the uptake was reduced. A mix- 
ture prepared by sonication in bile was even less ef- 
fectively taken up than that in ethanol. When 
polyprenols were dispersed in corn oil, the uptake 
into liver was reduced to 20% of that seen in the 
case of liposomes. Clearly, using the procedures 
described above for the solubilization of dietary 
lipids, the extent of lipid entering into the body was 
not substantially increased in comparison to the 
use of liposomes as carriers. 
The intracellular distributions of the dietary 
polyprenol-12 and dolichol-12 recovered in the 
Table 3 
Distribution of dietary polyisoprenols in liver fractions 
Fraction [3H]Polyprenol-12 [3H]Dolichol-12 
(dpm/g wet weight) (dpm/g wet weight) 
2000 × g pellet 13 195 _+ 1267 12 127 _+ 1237 
Mitochondria-lysosomes 62 861 + 7040 47 651 _+ 5242 
Microsomes 9409 _+ 734 1738 _+ 143 
Supernatant 913 + 93 526 + 52 
The values are the means _+ SE of 7 experiments 
Table 4 
Modification of dietary dolicho1-12 and polyprenol-12 in the liver 
Lipid Lipids Amount 
administered isolated (dpm/g wet weight) 
Dolichol-12 dolichol-12 40 623 _+ 4194 
dolichyl-12-ester 15 387 + 1416 
dolichyl-12-P 5538 _+ 620 
Polyprenol-12 c~-saturated polyprenol-12 35 846 + 3226 
c~-unsaturated polyprenol-12 13 940 +_ 1631 
polyprenyl-12-ester 26 339 +_ 3161 
polyprenyl-12-P 6832 _+ 687 
Dolichol- 12 or polyprenol-12 was given to the rats via a gastric tube. 20 h later the liver homogenates were prepared and extracted, and 
radioactivity was determined in the isolated lipid fractions. The values are the means _+ SE of 6 experiments 
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liver were determined by subfractionation (table 3). 
More than half of the polyisoprenols were found in 
the mitochondrial-lysosomal fr ction. Also, a 
relatively high polyprenol content was observed in 
the 2000 x g pellet. In addition to debris, this 
pellet contains mainly nuclei, which appear to ac- 
cumulate polyisoprenols to some extent. Both 
microsomes and the high-speed supernatant frac- 
tion contained only smaller amounts of labeled 
polyisoprenols. 
The lipids recovered in the liver homogenate 
were analyzed by HPLC and the radioactivity pres- 
ent in individual fractions determined. The data in 
table 4 demonstrate hat a portion of the poly- 
isoprenols taken up was modified enzymatically. 
One-third of the dolichol-12 taken up by the liver 
appeared in esterified form and a smaller portion, 
about 10070, was phosphorylated. Part of the 
polyprenol-12 was recovered in a-saturated form 
and, similar to the case of dolichol-12, this lipid 
was also esterified and phosphorylated. Under the 
conditions used here and during the time period 
employed, no sign of elongation of polyiso- 
prenoids was observed upon HPLC analysis. 
4. DISCUSSION 
The uptake of polyisoprenols from the intestine 
in rat occurs only to a limited extent (a few percent 
of total) and this uptake was not increased when 
the mixture administered was in ethanol solution, 
in bile or mixed with corn oil. The best results were 
obtained using unilamellar vesicles, but the ques- 
tion remains as to whether micellar forms which 
are taken up more effectively may exist. Specific 
lipids may interfer with hydrophobic interactions 
or surface charge. Alternatively, it may turn out 
that carrier proteins are involved and that the up- 
take of polyisoprenols proceeds via a receptor 
mechanism. 
The non-esterified polyisoprenols administered 
to the rat appeared inalle the organs examined with 
the highest uptake in the liver. Previous studies 
have established that the liver contains metabolic 
systems catalyzing terminal modifications of 
polyisoprenoid lipids [5]. These systems include the 
NADH-dependent a-saturase, which uses various 
polyprenols are substrate, the CTP-dependent 
dolichol kinase and the acyl-CoA:dolichol acyl- 
transferase. Clearly, these nzymes utilize not only 
endogenously s nthesized polyisoprenols, but also 
exogenous lipid taken up from the diet, since a- 
saturation, limited phosphorylation a d a relative- 
ly extensive sterification of the exogenous com- 
pounds were observed here. Since condensation 
with isopentenyl-PP requires the presence of a 
pyrophosphate leaving group, it is not surprising 
that in our system no elongation was observed. 
Upon subfractionation f the liver, most of the 
polyisoprenoids were recovered in the mito- 
chondrial-lysosomal fraction and was obviously 
mainly located in the lysosomes. This finding sug- 
gests that the uptake process is receptor-mediated 
and involves lipoproteins [13] in agreement with 
the fact that dolichol is associated with lipoproteins 
in the blood [14]. It also appears that most ex- 
trahepatic tissues utilize a mechanism for dolichol 
uptake which differs from that of the liver, since, 
in contrast to the liver, other tissues took esterified 
derivatives up to the same extent as the free 
alcohols. 
It is possible that in the future one may be able 
to identify conditions and pathways by which the 
entry of dietary polyprenols into the liver, as well 
as into other organs, may be increased. Altered 
physiological conditions or pathological processes 
may enhance uptake, as they enhance metabolic or 
catabolic reactions. A number of drug treatments 
influencing peroxisomes and the endoplasmic 
reticulum affect not only membrane synthesis 
and/or metabolic reactions uch as hydroxylation 
and/3-oxidation f fatty acids, but also rapidly in- 
crease dolichol content [15]. Under such conditions 
dietary uptake may supplement endogenous syn- 
thesis or maintain basic levels when synthesis is 
damaged or inhibited. 
Acknowledgements: This work was supported by the Swedish 
Medical Research Council and the Swedish Cancer Society. 
During part of this study T.C. was a visiting professor in 
Stockholm supported by the Swedish Medical Research 
Council. 
REFERENCES 
[1] Bloch, K (1985) in: Biochemistry of Lipids and Membranes 
(Vance, D.E. and Vance, J.E. eds) pp. 1-24, Benjamin/ 
Cumming, California. 
[2] Jayaraman, J. and Ramasarma, T. (1963) Arch. Biothem. 
Biophys. 103,258-266. 
35 
Volume 255, number 1 FEBS LETTERS September 1989 
[3] Chojnacki, T. and Dallner, G. (1983) J. Biol. Chem. 258, 
916-922. 
[4] Keller, R.K., Jehle, E. and Adair, W.L. (1982) J. Biol. 
Chem. 257, 8985-8989. 
[5] Chojnacki, T. and Dallner, G. (1988) Biochem. J. 251, 
1-9. 
[6] Tollbom, 0., Valtersson, C., Chojnacki, T. and Dallner, 
G. (1988) J. Biol. Chem. 263, 1347-1352. 
[7] Folch, J., Lees, M. and Sloane-Stanley, G.H. (1957) J. 
Biol. Chem. 226, 497-509. 
[8] Ekstr6m, T.J., Chojnacki, T. and Dallner, G. (1987) J. 
Biol. Chem. 262, 4090-4097. 
[9] Ekstr6m, T.J., Chojnacki, T. and Dallner, G. (1984) J. 
Biol. Chem. 259, 10460-10468. 
[10] Mankowski, T., Jankowski, W., Chojnacki, T. and 
Franke, P. (1976) Biochemistry 15, 2125-2130. 
[11] Keenan, R.W. and Kruczek, M.E. (1976) Biochemistry 15, 
1586-1591. 
[12] Pinter, K.G., Hamilton, J.G. and Muldey, J.E. (1964) 
J. Lipid Res. 5, 273-274. 
[13] Brown, M.S. and Goldstein, J.L. (1980) J. Lipid Res. 21, 
505-517. 
[14] Elmberger, P.G., Engfeldt, P. and Dallner, G. (1988) 
J. Lipid Res. 29, 1651-1662. 
[15] Edlund, C., Ericsson, J. and Dallner, G. (1987) Chem.- 
Biol. Interact. 62, 191-208. 
36 
